IMforte shows lurbinectedin plus atezolizumab maintenance extends PFS and OS in extensive-stage SCLC, with manageable cytopenias and key patient-selection guidance.

Incyte announced Friday that the FDA issued a complete response letter for its PD-1 inhibitor Zynyz as a first-line treatment for non-small cell lung cancer.

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

A group of doctors who specialize in cancer have detailed four subtle symptoms of the disease that people often overlook. The American Cancer Society predicts 2.1 million people in the US will be ...

John Avlon talks with Annabelle Gurwitch about surviving stage-4 lung cancer—and what her experience reveals about America’s broken health system.

An owl that was rescued by two organizations in Massachusetts is now helping to raise money for a good cause. The bird ...

The experience features surgical robotic technology designed to assist with lung cancer diagnosis and treatment. Lung cancer is often found in patients aged 65 and older. Dr. Angel Nunez, a ...

Costochondritis is not cancer, but its symptoms can resemble those of some types of cancer. It can also develop after certain ...

For years, routine screening recommendations have been limited to four cancers — breast, cervical, colorectal, and high-risk ...

More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...

Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts for a trio of Novartis’ blockbusters, Jeff Legos is now tasked with ...

Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...